Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine

J Postgrad Med. 2021 Jul-Sep;67(3):180-181. doi: 10.4103/jpgm.JPGM_254_21.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • BNT162 Vaccine
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / adverse effects
  • Female
  • Humans
  • Lymphadenopathy* / diagnostic imaging
  • Lymphadenopathy* / etiology
  • Remission, Spontaneous
  • SARS-CoV-2
  • Ultrasonography / methods

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine